Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-05

Clinical Trial Update: Evaluating the Feasibility of High-volume, Low-risk Penicillin Allergy De-labelling to Maximise Efficiency in a Resource-limited Setting [NA]

View source ↗

Summary

A clinical trial from University Hospital Southampton NHS Foundation Trust is evaluating the feasibility of high-volume, low-risk penicillin allergy de-labellin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Penicillin Allergy | NA | Status: NOT_YET_RECRUITING